Decreased surface sialic acid content is a sensitive indicator of muscle damage

Muscle and Nerve

Volumn 47, Issue 3, 2013, Pages 372-378

  Iwata, Yuko ^a   Suzuki, Osamu ^b   Wakabayashi, Shigeo ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

Lectin staining; Muscle injury; Muscular dystrophy; Sialic acid; Sialidase

Indexed keywords

DELTA SARCOGLYCAN; DYSTROPHIN; LECTIN; MEROSIN; SIALIC ACID; SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; FLUORESCENCE; HUMAN; HUMAN TISSUE; MOUSE; MUSCLE BIOPSY; MUSCLE INJURY; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE;

ANIMALS; BIOLOGICAL MARKERS; BIOPSY; CRICETINAE; CYTOSOL; FLUORESCENT DYES; HUMANS; LAMININ; LECTINS; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHIES; MUSCULAR DYSTROPHY, ANIMAL; N-ACETYLNEURAMINIC ACID; PEANUT AGGLUTININ; SARCOLEMMA;

EID: 84874252843     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23632     Document Type: Article

References (33)

1. Manzur AY, Muntoni F. Diagnosis and new treatments in muscular dystrophies. Postgrad Med J 2009;85:622-630.
2. Ervasti JM, Kahl SD, Campbell KP. Purification of dystrophin from skeletal muscle. J Biol Chem 1991;266:9161-9165.
3. Campbell KP, Kahl SD. Association of dystrophin and an integral membrane glycoprotein. Nature 1989;338:259-262.
4. Ebashi S, Toyokura Y, Momoi H, Sugita H. High creatine phosphokinase activity of sera of progressive muscular dystrophy. J Biochem (Tokyo) 1959;46:103-104.
5. Vassella F, Richterich R, Rossi E. The diagnostic value of serum creatine kinase in neuromuscular and muscular disease. Pediatrics 1965;35:322-330.
6. Nicholson GA, Morgan GJ, Meerkin M, Strauss ER, McLeod JG. The effect of aerobic exercise on serum creatine kinase activities. Muscle Nerve 1986;9:820-824.
7. Florence JM, Fox PT, Planer GJ, Brooke MH. Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology? Neurology 1985;35:758-761.
8. Straub V, Rafael JA, Chamberlain JS, Campbell KP. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol 1997;139:375-385.
9. Kanagawa M, Nishimoto A, Chiyonobu T, Takeda S, Miyagoe-Suzuki Y, Wang F, et al. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy. Hum Mol Genet 2009;18:621-631.
10. Montanaro F, Carbonetto S. Targeting dystroglycan in the brain. Neuron 2003;37:193-196.
11. Chiba A, Matsumura K, Yamada H, Inazu T, Shimizu T, Kusunoki S, et al. Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of alpha-dystroglycan with laminin. J Biol Chem 1997;272:2156-2162.
12. Grewal PK, Hewitt JE. Glycosylation defects: a new mechanism for muscular dystrophy? Hum Mol Genet 2003;12( spec no 2):R259-264.
13. Endo T. Dystroglycan glycosylation and its role in alpha-dystroglycanopathies. Acta Myol 2007;26:165-170.
14. Varki NM, Varki A. Diversity in cell surface sialic acid presentations: implications for biology and disease. Lab Invest 2007;87:851-857.
15. Schauer R. Achievements and challenges of sialic acid research. Glycoconj J 2000;17:485-499.
16. Schwarzkopf M, Knobeloch KP, Rohde E, Hinderlich S, Wiechens N, Lucka L, et al. Sialylation is essential for early development in mice. Proc Natl Acad Sci USA 2002;99:5267-5270.
17. Dairaku K, Miyagi T, Wakui A, Tsuiki S. Cytosolic sialidases of rat tissues with special reference to skeletal muscle enzyme. Biochem Int 1986;13:741-748.
18. Tajima Y, Uyama E, Go S, Sato C, Tao N, Kotani M, et al. Distal myopathy with rimmed vacuoles: impaired O-glycan formation in muscular glycoproteins. Am J Pathol 2005;166:1121-1130.
19. Eisenberg I, Avidan N, Potikha T, Hochner H, Chen M, Olender T, et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001;29:83-87.
20. Noguchi S, Keira Y, Murayama K, Ogawa M, Fujita M, Kawahara G, et al. Reduction of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase activity and sialylation in distal myopathy with rimmed vacuoles. J Biol Chem 2004;279:11402-11407.
21. 2+-permeable growth factor-regulated channel. J Cell Biol 2003;161:957-967.
22. Suzuki O, Kanai T, Nishikawa T, Yamamoto Y, Noguchi A, Takimoto K, et al. Adult onset cardiac dilatation in a transgenic mouse line with Galβ1, 3GalNAc α2, 3-sialyltransferase II (ST3Gal-II) transgenes: a new model for dilated cardiomyopathy. Proc Jpn Acad Ser B 2011;87:550-562.
23. Ervasti JM, Campbell KP. Dystrophin and the membrane skeleton. Curr Opin Cell Biol 1993;5:82-87.
24. Malicdan MC, Noguchi S, Hayashi YK, Nonaka I, Nishino I. Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 2009;15:690-695.
25. Schwetz TA, Norring SA, Ednie AR, Bennett ES. Sialic acids attached to O-glycans modulate voltage-gated potassium channel gating. J Biol Chem 286:4123-4132.
26. + channel NaV1.4 in Chinese hamster ovary cells. Pharmacology 87:311-317.
27. Kudryashova E, Kramerova I, Spencer MJ. Satellite cell senescence underlies myopathy in a mouse model of limb-girdle muscular dystrophy 2H. J Clin Invest 122:1764-1776.
28. Sato Y, Endo T. Alteration of brain glycoproteins during aging. Geriatr Gerontol Int 2010;10(suppl 1):S32-40.
29. Hadengue AL, Del-Pino M, Simon A, Levenson J. Erythrocyte disaggregation shear stress, sialic acid, and cell aging in humans. Hypertension 1998;32:324-330.
30. 2+ homeostasis and cell damage in myopathic skeletal muscle cells. Biochem Pharmacol 2005;70:740-751.
31. Stibler H, Sydow O. Carbohydrate composition of erythrocyte membranes and glycosidase activities in serum in patients with myotonic dystrophy, limb-girdle dystrophy and congenital myotonia. J Neurol Sci 1984;63:285-298.
32. Bailey LE. Orotic acid prevents changes in cardiac sarcolemmal glycoproteins and contractility associated with muscular dystrophy in hamsters. Experientia 1980;36:94-95.
33. Laflamme MA, Murry CE. Heart regeneration. Nature 2011;473:326-335.